These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26492443)

  • 21. Activated protein C resistance testing for factor V Leiden.
    Kadauke S; Khor B; Van Cott EM
    Am J Hematol; 2014 Dec; 89(12):1147-50. PubMed ID: 25293789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
    Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
    J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma homocysteine concentration is not associated with activated protein C resistance in patients investigated for hypercoagulability.
    Zarychanski R; Houston DS
    Thromb Haemost; 2004 Jun; 91(6):1115-22. PubMed ID: 15175797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procoagulant and anticoagulant properties of coagulation factor V: factor V Leiden (APC resistance) causes hypercoagulability by dual mechanisms.
    Dahlbäck B
    J Lab Clin Med; 1999 May; 133(5):415-22. PubMed ID: 10235124
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiology patient page. Factor V Leiden.
    Ornstein DL; Cushman M
    Circulation; 2003 Apr; 107(15):e94-7. PubMed ID: 12707252
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful Living-Related Renal Allograft in a Recipient With Factor V Leiden Deficiency: A Case Report.
    Florou E; Koukoulaki M; Theodoros T; Kalatzis V; Vougas V; Stamataki E; Kokkinou VC; Kostakis A; Drakopoulos S
    Exp Clin Transplant; 2017 Feb; 15(1):96-99. PubMed ID: 26102090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP; Blombäck M
    Thromb Res; 2002 Apr; 106(1):59-62. PubMed ID: 12165290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers.
    Gaber Y; Siemens HJ; Schmeller W
    Br J Dermatol; 2001 Mar; 144(3):546-8. PubMed ID: 11260012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor V Leiden, activated protein C resistance, and retinal vein occlusion.
    Ciardella AP; Yannuzzi LA; Freund KB; DiMichele D; Nejat M; De Rosa JT; Daly JR; Sisco L
    Retina; 1998; 18(4):308-15. PubMed ID: 9730172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory Testing for Activated Protein C Resistance (APCR): An Update.
    Favaloro EJ; Mohammed S; Vong R; Pasalic L
    Methods Mol Biol; 2023; 2663():203-210. PubMed ID: 37204711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.
    Sartori MT; Simioni P; Patrassi GM; Theodoridis P; Tormene D; Girolami A
    Clin Appl Thromb Hemost; 2000 Jan; 6(1):36-40. PubMed ID: 10726047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee.
    Moore GW; Castoldi E; Teruya J; Morishita E; Adcock DM
    J Thromb Haemost; 2023 Jan; 21(1):164-174. PubMed ID: 36695379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Method-dependent influence of certain polymorphisms in the factor V B-domain on the response to activated protein C.
    Siegert G; Kostka H; Gehrisch S; Schwarz T; Schellong S; Jaross W
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):519-27. PubMed ID: 10997791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory diagnosis of hereditary thrombophilia.
    Michiels JJ; Hamulyák K
    Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma.
    Reuner KH; Litfin F; Patscheke H
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):41-5. PubMed ID: 9156566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [APC resistance--most frequent familial thrombophilia].
    Herren S; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):499-501. PubMed ID: 10517118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predictability of factor V Leiden (FV:Q(506)) gene mutation via clotting-based diagnosis of activated protein C resistance.
    Sayinalp N; Haznedaroğlu IC; Aksu S; Büyükaşik Y; Göker H; Parlak H; Ozcebe OI; Kirazli S; Dündar SV; Gürgey A
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):265-70. PubMed ID: 15247984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss.
    Younis JS; Brenner B; Ohel G; Tal J; Lanir N; Ben-Ami M
    Am J Reprod Immunol; 2000 Jan; 43(1):31-5. PubMed ID: 10698038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications.
    Zangari M; Saghafifar F; Anaissie E; Badros A; Desikan R; Fassas A; Mehta P; Morris C; Toor A; Whitfield D; Siegel E; Barlogie B; Fink L; Tricot G
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):187-92. PubMed ID: 11943931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis of thrombophilia]].
    Kemkes-Matthes B
    Zentralbl Chir; 2001 Jun; 126(6):433-7. PubMed ID: 11446062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.